Skip to main content
RT @DrCassySims: 💤Our PsA patients are not sleeping well 💤

Abstract #0387 #ACR22 @RheumNow

😴 247 patients, s

Catherine Sims, MD DrCassySims

3 years 11 months ago
💤Our PsA patients are not sleeping well 💤 Abstract #0387 #ACR22 @RheumNow 😴 247 patients, sleep quality measured via PSQI 🛌 63% had poor sleep quality 💤 Worse sleep associated with female sex, higher disease activity, fatigue, anxiety/depression https://t.co/Wy20qx2Ah4
RT @RHEUMarampa: To taper or not to taper?
In this prospective study by Dr. Cho, #SLE patients in complete remission had

sheila RHEUMarampa

3 years 11 months ago
To taper or not to taper? In this prospective study by Dr. Cho, #SLE patients in complete remission had a longer time to flare upon drug tapering vs. those in LLDAS or clinical remission states. #ACR22 @RheumNow ABST#0996 #ACRBEst @rheumarhyme https://t.co/bSGlkc7Tvk
RT @uptoTate: #ACR22 Abs 1752 finds rates of incident cancer did not differ between patients treated with anti-TNF and o

Dr. Rachel Tate uptoTate

3 years 11 months ago
#ACR22 Abs 1752 finds rates of incident cancer did not differ between patients treated with anti-TNF and other bDMARDs or tsDMARDs. @RheumNow https://t.co/ycnQzrmAjw https://t.co/CSgDq2Gazg
RT @uptoTate: Abs 1757 at #ACR22 finds women w/ gout have a higher risk of all-cause mortality, which is primarily drive

Dr. Rachel Tate uptoTate

3 years 11 months ago
Abs 1757 at #ACR22 finds women w/ gout have a higher risk of all-cause mortality, which is primarily driven by higher risk of CVD deaths. @RheumNow https://t.co/kPDL2VYRCN https://t.co/9qARr7T4fI
RT @uptoTate: Abs L04 reviews novel humanized murine model of PsA disease phenotypes mediated by CD8 T Cells. Perhaps th

Dr. Rachel Tate uptoTate

3 years 11 months ago
Abs L04 reviews novel humanized murine model of PsA disease phenotypes mediated by CD8 T Cells. Perhaps this is a step forward in personalized medicine. #ACR22 @RheumNow https://t.co/fPoElqFLI7 https://t.co/4pxBKoPnym
RT @RHEUMarampa: Prof Petri presents mortality data of their #lupus cohort
🔅55 yrs - ave age of death from all causes

sheila RHEUMarampa

3 years 11 months ago
Prof Petri presents mortality data of their #lupus cohort 🔅55 yrs - ave age of death from all causes Top 4 common causes of death: 🔅SLE 🔅CVD 🔅Cancer 🔅Infection African-americans had ⬆️proportions of death from infections & renal causes #ACR22 @RheumNow #ABST2068 https://t.co/B5cAfZiRJp
RT @RHEUMarampa: Is sustained B cell depletion assoc w/⬇️dse flares in #lupus nephritis?
In this study by Dr D Zisa,

sheila RHEUMarampa

3 years 11 months ago
Is sustained B cell depletion assoc w/⬇️dse flares in #lupus nephritis? In this study by Dr D Zisa, pts treated w/ BCA & had sustained Bcell depletion = ⬇️dse flares 👉Rapid repletion to BCC>100c/uL was assocd w/ 15.2x risk for flares #ACR22 @RheumNow ABST2065 https://t.co/ivSjm98YvZ
RT @doctorRBC: Is there a difference between IL-17i and TNFi in preventing radiographic progression in radiographic axSp

Robert B Chao, MD doctorRBC

3 years 11 months ago
Is there a difference between IL-17i and TNFi in preventing radiographic progression in radiographic axSpA? Head to head study secukinumab vs. adalimumab biosimilar shows no sig difference with low radiographic progression. #ACRBest Abs#L15 @RheumNow #ACR22 https://t.co/UiHMtakaPz
RT @uptoTate: Clinical pearl! Abs 1790 at #ACR22 finds bilateral US assessment of knees, wrists and hips provided the be

Dr. Rachel Tate uptoTate

3 years 11 months ago
Clinical pearl! Abs 1790 at #ACR22 finds bilateral US assessment of knees, wrists and hips provided the best sensitivity and specificity for diagnosing CPPD. @RheumNow https://t.co/3zlrNGCek4 https://t.co/hPK3eMH6iY
RT @AkhilSoodMD: Are we screening & tx approp. for HBV in #IIM?
Abstr #1864 found:
- 78% IIM pts were screened for H

Akhil Sood MD AkhilSoodMD

3 years 11 months ago
Are we screening & tx approp. for HBV in #IIM? Abstr #1864 found: - 78% IIM pts were screened for HBV (mean time 21 months from time of dx) - 73% Hep B Core Ab+ on RTX received Ppx tx - IIM pts Hep B Core Ab+ ↑ % +myositis spec ab and reach remission w/ IVIG @RheumNow #ACR22 https://t.co/QlQxGlkIhh
RT @uptoTate: Denosumab for erosive hand OA? Abs L05 shows less erosive progression at week 24 with enhancement, includ

Dr. Rachel Tate uptoTate

3 years 11 months ago
Denosumab for erosive hand OA? Abs L05 shows less erosive progression at week 24 with enhancement, including pain symptom improvement, at week 48. I can't wait to see more on this! #ACRbest #ACR22 @RheumNow https://t.co/aYb1biVgqt https://t.co/xHXj7nu1IJ
RT @uptoTate: Uric acid appears to be negatively associated with bone mineral density in premenopausal but not in postme

Dr. Rachel Tate uptoTate

3 years 11 months ago
Uric acid appears to be negatively associated with bone mineral density in premenopausal but not in postmenopausal women with RA in Abs 1826 #ACR22 @RheumNow https://t.co/Cus73EeMDP https://t.co/e6mrEw4mR4
RT @RHEUMarampa: #lupus pts w/ SKIN involvement had lower HRQoL by SF-36 than those w/o skin involvement as reported by

sheila RHEUMarampa

3 years 11 months ago
#lupus pts w/ SKIN involvement had lower HRQoL by SF-36 than those w/o skin involvement as reported by Dr Alician Van from their study. Significance?⬆️ awareness so we can improve coping strategies & support for these pts. #ACR22 @RheumNow ABST#2089 @rheumarhyme @doktora_ging https://t.co/BKKl8BCN9y
RT @AkhilSoodMD: Are we seeing ↑ MDA-5 associated DM post-COVID?
Abstr #1857 found since start of pandemic
- ↑ in %

Akhil Sood MD AkhilSoodMD

3 years 11 months ago
Are we seeing ↑ MDA-5 associated DM post-COVID? Abstr #1857 found since start of pandemic - ↑ in % of myositis specific ab testing - ↑ +MDA-5 since onset of pandemic Conclusion: It is possible but we need more data (n = and longitudinal f/u) @RheumNow #ACR22 https://t.co/ZdfDdFc2hZ
RT @DrPetryna: #Abst1669 #ACR22 @RheumNow retrospective study of pts w/checkpoint inhibitor associated arthritis: Rx w/

Olga Petryna DrPetryna

3 years 11 months ago
#Abst1669 #ACR22 @RheumNow retrospective study of pts w/checkpoint inhibitor associated arthritis: Rx w/ TNFi ± MTX or IL6Ri ± MTX assoctd w/shorter time to cancer progression but faster arthritis control vs pts treated w/MTX alone. optimal approach yet to be identified #ACRBest https://t.co/lyR2C6zR80
×